Clinical Trials on Søvnapné, obstruktiv

Total 9838 results

Pearl Therapeutics, Inc.

Completed

Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Australia, New Zealand
Lutheran Hospital, Indiana
Fisher and Paykel Healthcare

Unknown

The Efficacy of the AIRVO Warm Humidifier as an Add on to Oxygen Therapy

Chronic Obstructive Pulmonary Disease | COPD

United States
Novartis Pharmaceuticals

Completed

To Determine the Relationship Between Baseline Reversibility and the Efficacy of Indacaterol (REVERBREZ)

Chronic Obstructive Pulmonary Disease (COPD)

France
Rigshospitalet, Denmark

Completed

Mechanisms of Exercise Intolerance in Chronic Obstructive Pulmonary Disease (COPD)

COPD

Denmark
Maquet Cardiopulmonary AG

Withdrawn

The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD) (PALP-COPD)

Chronic Obstructive Pulmonary Disease | COPD

Germany
Novartis Pharmaceuticals

Completed

A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation

Chronic Obstructive Pulmonary Disease (COPD)

United States, Colombia, Egypt, Hungary, France, Guatemala, Panama, Slovakia, Slovenia
McGill University Health Centre/Research Institute...
GlaxoSmithKline

Completed

Strategy for Early Treatment of Exacerbations in COPD: Standing Prescriptions of Advair With a Written Action Plan in the Event of an Exacerbation

Chronic Obstructive Pulmonary Disease | COPD

Canada
Fudan University
The First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaborators

Unknown

The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD

Chronic Obstructive Pulmonary Disease (COPD)

China
University of Michigan
National Heart, Lung, and Blood Institute (NHLBI)

Completed

RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative (RETHINC)

COPD (Chronic Obstructive Pulmonary Disease)

United States
University of Alberta
University of Calgary

Completed

Examining Vascular Outcomes in COPD Inpatients (AIM 1) Examining Early Rehabilitation on Discharged COPD Patients (AIM 2)

Chronic Obstructive Pulmonary Disease (COPD)

Canada
Sunovion Respiratory Development Inc.

Completed

A Clinical Study to Investigate if a Single Dose of an Approved Drug Product (Glycopyrrolate Inhalation Solution) Reduces Trapped Air in the Lungs of Participants With Chronic Obstructive Pulmonary Disease.

Chronic Obstructive Pulmonary Disease (COPD)

United States
Cairo University

Completed

Effect of Magnesium Sulphate Infusion on Lung Mechanics and Oxygenation in COPD Patients Undergoing Total Laryngeal (COPD)

Chronic Obstructive Pulmonary Diseases

Egypt
University of California, San Francisco
Patient-Centered Outcomes Research Institute

Completed

Aides in Respiration Health Coaching for COPD (AIR)

Chronic Obstructive Pulmonary Disease (COPD)

United States
University of Zurich

Completed

Patients With Chronic Obstructive Pulmonary Disease at Altitude - Effect of Nocturnal Oxygen on Breathing and Sleep

Chronic Obstructive Pulmonary Disease (COPD)

Switzerland
Merck Sharp & Dohme LLC

Terminated

Exercise Study in Patient With Chronic Obstructive Pulmonary Disease (0000-036)

Chronic Obstructive Pulmonary Disease (COPD)
Medical University of Lodz

Completed

A Pragmatic Cluster Trial of a Tailored Intervention to Improve COPD Management (TICD-COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Poland
Zhujiang Hospital
Guangzhou Panyu Central Hospital

Completed

Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

China
University of Milan
Università degli Studi di Ferrara; Fondazione Salvatore Maugeri

Completed

Nitric Oxyde Concentration in Chronic Obstructive Pulmonary Disease Patients - SANOB Study (SANOB)

Chronic Obstructive Pulmonary Disease (COPD)

Italy
Sheba Medical Center
Clalit Health Services

Completed

Comprehensive Disease Management Program in Chronic Obstructive Pulmonary Disease (COPD) Patients in the Community (COPD_CDM)

Chronic Obstructive Pulmonary Disease (COPD)

Israel
University of Zurich

Completed

Patients With Chronic Obstructive Pulmonary Disease At Altitude

Chronic Obstructive Pulmonary Disease (COPD)

Switzerland
AstraZeneca

Completed

Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) (SECURE 1)

Chronic Obstructive Pulmonary Disease (COPD)

Korea, Republic of, China, Hong Kong, Thailand, Indonesia
Zhujiang Hospital

Unknown

Effects of Inspiratory and Expiratory Pressure Training Methods in Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease(COPD)

China
Dey

Completed

A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States
Helios Klinik Ambrock

Completed

Transnasal Insufflation (TNI) and Chronic Obstructive Pulmonary Disease (TNICOPD)

Chronic Obstructive Pulmonary Disease (COPD)

Germany
Vinmec Research Institute of Stem Cell and Gene...

Recruiting

Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease

COPD

Vietnam
AstraZeneca
Parexel

Completed

A Study to Assess Drug Absorption of Fixed Dose Combinations of Budesonide, Glycopyrronium, and Formoterol

Chronic Obstructive Pulmonary Disease (COPD)

United States
Chiesi Farmaceutici S.p.A.

Completed

2-arm Parallel Group Study of Fixed Combination of CHF 5993 vs Ultibro® in COPD Patients (TRIBUTE)

Chronic Obstructive Pulmonary Disease (COPD)

Italy
Chiesi Farmaceutici S.p.A.

Completed

Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration (GLY2)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Pearl Therapeutics, Inc.

Completed

Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

COPD

United States
Guangzhou Institute of Respiratory Disease

Completed

Quality Control for Chronic Obstructive Pulmonary Disease

COPD

China
Bayside Health
Newcastle University; Austin Health

Completed

Effect of Exercise Training on Salivary Immunoglobulin A in Patients With Chronic Obstructive Pulmonary Disease

COPD

Australia
Fisher and Paykel Healthcare
Medical Research Institute of New Zealand; Alana Healthcare

Terminated

Nasal High Flow Therapy 30 Day Readmission Study (N3ADS)

Chronic Obstructive Pulmonary Disease | COPD

United States, New Zealand
Chiesi Farmaceutici S.p.A.

Completed

Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD (GlycoNEXT)

Chronic Obstructive Pulmonary Disease (COPD)

Czechia, Germany, Hungary, Romania
Cardiff University
GlaxoSmithKline; Cardiff Metropolitan University

Completed

Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
AstraZeneca

Completed

Phase IV O2 Consumption Study in COPD Patients.

Chronic Obstructive Pulmonary Disease (COPD)

United States
Sunovion Respiratory Development Inc.

Completed

A Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (GOLDEN-2)

COPD

United States
Assiut University

Unknown

VSV Versus PSV as a Weaning Mode of Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients

COPD

Egypt
Radboud University Medical Center

Unknown

Exacerbation Self-management in COPD: The ACCESS Study (ACCESS)

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands
Brigham and Women's Hospital
AstraZeneca

Terminated

Changes in Cardiac Function in COPD Patients After Administration of Budesonide/Formoterol (Symbicort®) Versus Placebo (AZCO)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Pearl Therapeutics, Inc.

Completed

Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2)

Chronic Obstructive Pulmonary Disease (COPD)

United States
University of Aarhus
Aarhus University Hospital

Completed

Magnesium is Associated With QoL in COPD: A Cross-sectional Study

Chronic Obstructive Pulmonary Disease (COPD)

Denmark
Universidad de Granada

Completed

Physiotherapy in Patients With Stable Chronic Obstructive Pulmonary Disease

COPD

Spain
Medical University of Warsaw

Unknown

Effects of Osteopathic Techniques on Residual Volume in Severe Chronic Obstructive Pulmonary Disease

COPD

Poland
University Hospital Southampton NHS Foundation...
GlaxoSmithKline

Completed

Microbiology & Immunology of the Chronically-inflamed Airway (MICA)

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Novartis Pharmaceuticals

Completed

A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation

Chronic Obstructive Pulmonary Disease (COPD)

United States, Romania, Hungary, Bulgaria, Spain, Finland, Puerto Rico
Novartis Pharmaceuticals

Completed

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

Chronic Obstructive Pulmonary Disease (COPD)

United States, Poland, Romania, Canada, Philippines, Spain, Ukraine, Vietnam
Eisai Co., Ltd.

Completed

Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study

COPD

Japan
Fundación Pública Andaluza Progreso y Salud

Completed

Roflumilast Safety Administered Once a Day on Alternate Days for Two Weeks Compared to the Usual Dosage Once Daily (ROFLU2011)

Chronic Obstructive Pulmonary Disease (COPD)

Spain
COPD Foundation
National Jewish Health

Completed

COPD Research Registry

Chronic Obstructive Pulmonary Disease (COPD)

United States
Lallemand Pharma AG
Sprim Advanced Life Sciences

Completed

Advanced Immunological Approach in COPD Exacerbation (AIACE)

Chronic Obstructive Pulmonary Disease (COPD)

Italy

3

Subscribe